1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p7)

Biological Therapy Analysis & Statistics, November 2016 (p7)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

181-210 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Osteonecrosis - Pipeline Review, H2 2016

Osteonecrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy
  • Countries : United Kingdom, World
Global 3D Bioprinting Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Technology, by Application

Global 3D Bioprinting Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Technology, by Application

  • $ 5100
  • Industry report
  • November 2016
  • by P&S Market Research

3D bioprinting refers to the process of creating 3D structures using live cells. The process uses 3D printing technologies for crating live cells or tissue structures. These structures are used for applications ...

  • Industries : Biological Therapy
  • Countries : China, World
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016

Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016

  • $ 1950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016”, report provides comprehensive insights about pipeline drugs across this indication. Key objective ...

  • Industries : Biological Therapy
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Muscular Dystrophy - Pipeline Review, H2 2016

Muscular Dystrophy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Muscular Dystrophy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
Critical Limb Ischemia - Pipeline Review, H2 2016

Critical Limb Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Critical Limb Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia – Pipeline Review, H2 2016, provides ...

  • Industries : Biological Therapy, Chronic Disease, Pathology
  • Countries : United States
U.S. Stem Cell, Inc. (USRM) - Medical Equipment - Deals and Alliances Profile

U.S. Stem Cell, Inc. (USRM) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary U.S. Stem cell Inc (U.S. Stem cell), formerly Bioheart, Inc, is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The ...

  • Industries : Biological Therapy
  • Countries : United States
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict ...

  • Industries : General Medicine and Specialty Medicine
Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile

Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated ...

  • Industries : Cancer, Biological Therapy, Pathology
Global Stem Cell Assay Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

Global Stem Cell Assay Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

The global market of stem cell assay is anticipated to reach USD 1,367.3 Million by 2022 at a CAGR of 21.5% during 2016 to 2022. Due to Rising Investment in Research Related Activities, Funding for Stem ...

  • Industries : Biological Therapy
  • Countries : World
Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

"Global 3D Cell Culture Market Research Report 2016" by OBRC, is an extensive study on present state of the 3D Cell Culture Market. 3D cell culture allows culturing of cells in a 3D environment. Adoption ...

  • Industries : Biological Therapy
  • Countries : World
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2016

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Factor 2 (Basic ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology, Therapy
  • Countries : United States
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, ...

  • Industries : Biological Therapy, Cancer, Pathology, Therapy, Biotechnology
  • Countries : United States, Mexico, World
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2013 To 2024

Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2013 To 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global scaffold technology market is anticipated to reach USD 1.5 billion by 2024, according to a new report by Grand View Research, Inc.Evolution of scaffold technology, which facilitates the transplantation ...

  • Industries : Biological Therapy
  • Countries : World
Cell Isolation/Cell Separation Market by Product, Cell Type, Technique, Application, End User - Global Forecast to 2021

Cell Isolation/Cell Separation Market by Product, Cell Type, Technique, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global cell isolation market is expected to reach USD 7.89 billion by 2021 from USD 3.57 billion in 2016, at a CAGR of 17.2%. On the basis of product, the cell isolation market is segmented into consumables ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Europe, Asia, North America, United States
PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : North America, World
Global Cell Expansion Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

Global Cell Expansion Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

The global Cell Expansion market is estimated to grow at CAGR of 18.1% during 2016-2022. The Cell Expansion is segmented on the basis of application, cell type, product, end user and geography. The application ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cell Therapy Market Analysis & Trends - Application, Treatment type - Forecast to 2025

Stem Cell Therapy Market Analysis & Trends - Application, Treatment type - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Stem Cell Therapy Market is poised to grow at a CAGR of around 36.4% over the next decade to reach approximately $1.55 billion by 2025. Some of the prominent trends that the market is witnessing ...

  • Industries : Biological Therapy, Pathology
  • Countries : United States
Cell Culture Market Analysis & Trends - Product(Consumables(Reagents, Sera & Media), Equipment(Bioreactors & Cell Culture Vessels)), End User (Pharmaceutical & Biotechnology Companies), Application - Forecast to 2025

Cell Culture Market Analysis & Trends - Product(Consumables(Reagents, Sera & Media), Equipment(Bioreactors & Cell Culture Vessels)), End User (Pharmaceutical & Biotechnology Companies), Application - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Cell Culture Market is poised to grow at a CAGR of around 11.4% over the next decade to reach approximately $33.47 billion by 2025. Some of the prominent trends that the market is witnessing ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World, United States
Cell Separation Techniques Market Analysis & Trends – Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Technique (Centrifugation, Filtration, Surface Marker) - Forecast to 2025

Cell Separation Techniques Market Analysis & Trends – Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Technique (Centrifugation, Filtration, Surface Marker) - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Cell Separation Techniques Market is poised to grow at a CAGR of around 10.6% over the next decade to reach approximately $6.04 billion by 2025. Some of the prominent trends that the market ...

  • Industries : Biological Therapy
  • Countries : United States
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

  • Industries : Therapy, Chronic Disease, Pathology, Pharmaceutical
  • Countries : World
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer vaccines are being ...

  • Industries : Therapy, Oncology
  • Countries : World
Cell Expansion - Global Market Outlook (2016-2022)

Cell Expansion - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cell expansion market is accounted for $7.23 billion in 2015 and is expected to reach $23.86 billion by 2022 growing at a CAGR of 18.59%. Increasing R&D investments ...

  • Industries : Biological Therapy
  • Countries : World, Asia, North America, Europe
Global Hematopoietic Stem Cell Transplantation Market Analysis & Trends - Application (Solid Tumors, Leukemia, Non-malignant Disorders and Lymphoproliferative Disorders), Transplant Type - Forecast to 2025

Global Hematopoietic Stem Cell Transplantation Market Analysis & Trends - Application (Solid Tumors, Leukemia, Non-malignant Disorders and Lymphoproliferative Disorders), Transplant Type - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Hematopoietic Stem Cell Transplantation Market is poised to grow at a CAGR of around 11.4% over the next decade to reach approximately $10.9 billion by 2025. Some of the prominent trends that ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
  • Countries : World, Europe, Asia, North America
Global 3D Cell Culture Market Analysis 2016 - Forecast to 2022

Global 3D Cell Culture Market Analysis 2016 - Forecast to 2022

  • $ 4550
  • Industry report
  • November 2016
  • by Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies

  • $ 220
  • Industry report
  • November 2016
  • by La Merie Publishing

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information about Bispecific Antibodies released during the month of Octobe ...

  • Industries : Biological Therapy

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.